BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stark T, Iannotti FA, Di Martino S, Di Bartolomeo M, Ruda-kucerova J, Piscitelli F, Wotjak CT, D’addario C, Drago F, Di Marzo V, Micale V. Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia. Biomolecules 2022;12:108. [DOI: 10.3390/biom12010108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Malik JA, Yaseen Z, Thotapalli L, Ahmed S, Shaikh MF, Anwar S. Understanding translational research in schizophrenia: A novel insight into animal models. Mol Biol Rep 2023. [PMID: 36692676 DOI: 10.1007/s11033-023-08241-7] [Reference Citation Analysis]
2 Micale V, Di Bartolomeo M, Di Martino S, Stark T, Dell'Osso B, Drago F, D'Addario C. Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets. Pharmacol Ther 2023;241:108279. [PMID: 36103902 DOI: 10.1016/j.pharmthera.2022.108279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Morén C, Treder N, Martínez-pinteño A, Rodríguez N, Arbelo N, Madero S, Gómez M, Mas S, Gassó P, Parellada E. Systematic Review of the Therapeutic Role of Apoptotic Inhibitors in Neurodegeneration and Their Potential Use in Schizophrenia. Antioxidants 2022;11:2275. [DOI: 10.3390/antiox11112275] [Reference Citation Analysis]